Skip to main content
. 2023 Dec 28;15(12):e51208. doi: 10.7759/cureus.51208

Table 5. Secondary outcome of the studied patients.

Data are displayed as mean ± SD or frequency (%), ERAS: enhanced recovery after surgery, PONV: postoperative nausea and vomiting, *: statistically significant as P value<0.05, P1: p value between no ERAS and ERAS in the first cycle, P2: p value between no ERAS and ERAS in the second cycle, P3: P1: p value between ERAS in the first cycle and the second cycle.

  No ERAS (n=22) ERAS in the first cycle (n=20) ERAS in the second cycle (n=23) P value Post hoc
Time of first flatus (days) 5.09 ± 1.54 1.65 ± 0.49 1.48 ± 0.51 <0.001* P1 <0.001*
P2 <0.001*
P3= 0.269
Time of first oral intake 4.5 ± 1.34 days 8.5 ± 2.33 h 8.52 ± 1.81 h <0.001* P1 <0.001*
P2 <0.001*
P3= 0.973
Time of first solid meal  (days) 6.23 ± 0.92 3.0 ± 0.73 3.3 ± 0.97 <0.001* P1 <0.001*
P2 <0.001*
P3= 0.258
PONV 4 (18.2%) 1 (5%) 3 (13%) 0.426 ---